Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;20(2):295-301.
doi: 10.1128/CVI.00649-12. Epub 2012 Dec 26.

Serodiagnostic potential of Mycobacterium avium MAV2054 and MAV5183 proteins

Affiliations

Serodiagnostic potential of Mycobacterium avium MAV2054 and MAV5183 proteins

A-Rum Shin et al. Clin Vaccine Immunol. 2013 Feb.

Abstract

The Mycobacterium avium-M. intracellulare complex (MAC) causes a pulmonary disease (PD) similar to tuberculosis (TB). Diagnosis of MAC-PD is complicated and time-consuming. In this study, the serodiagnostic potential of the newly identified MAV2054 and MAV5183 proteins was evaluated in subjects with MAC-PD, pulmonary TB, or latent TB and in noninfected healthy controls (HC), together with HspX and the 38-kDa antigen, well-known serodiagnostic M. tuberculosis antigens. All four antigens evoked significantly higher IgG responses in MAC-PD and active TB than in latent TB and HC subjects. Among the antigens, MAV2054 elicited the highest antibody responses in pulmonary TB and MAC-PD patients. IgG titers against MAV2054 and MAV5183 were significantly higher in MAC-PD than in pulmonary TB subjects. In addition, the levels of IgG against all antigens in the M. intracellulare and fibrocavitary forms were higher than those in the M. avium and nodular bronchiectatic forms, respectively. Based on sensitivity and receiver operator characteristic curve analysis, the best candidates for detection of MAC-PD and pulmonary TB were MAV2054 and the 38-kDa antigen, respectively. In total, 76.0% of MAC-PD and 65.0% of active TB patients were reactive to at least two antigens. In contrast, only 2.8% of HC subjects were reactive with two or more antigens. Our findings suggest that an enzyme-linked immunosorbent assay (ELISA) using the four antigens would be valuable for screening for mycobacterial lung disease, including MAC-PD and pulmonary TB, although it does not provide good discrimination of the disease-causing pathogens.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Identification of strong MAV2054 and MAV5183 seroreactivity in MAC-PD patients. An ammonium sulfate precipitate of M. avium CFP was fractionated by hydrophobic interaction chromatography using phenyl Sepharose. Each of the primary fractions was further fractionated by hydroxyapaptite chromatography. The third fractionation was conducted by DEAE ion-exchange chromatography. IgG titers in all fractions of sera from MAC-PD, pulmonary TB, and HC subjects were determined by ELISA. Two fractions, F15 (A) and F30 (B), were selected, subjected to SDS-PAGE, and stained with Coomassie brilliant blue.
Fig 2
Fig 2
SDS-PAGE analysis of purified recombinant MAV2054 (A) and MAV5183 (B) proteins. The proteins were overexpressed in E. coli, purified by Ni-NTA affinity chromatography, and analyzed by SDS-PAGE with Coomassie brilliant blue staining. Each lane was loaded with 20 μg protein. Bars indicate molecular mass.

Similar articles

Cited by

References

    1. Herdman AV, Steele JC., Jr 2004. The new mycobacterial species—emerging or newly distinguished pathogens. Clin. Lab. Med. 24:651–690 - PubMed
    1. Falkinham JO, III, Iseman MD, de Haas P, van Soolingen D. 2008. Mycobacterium avium in a shower linked to pulmonary disease. J. Water Health 6:209–213 - PubMed
    1. Huard RC, Lazzarini LC, Butler WR, van Soolingen D, Ho JL. 2003. PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J. Clin. Microbiol. 41:1637–1650 - PMC - PubMed
    1. Anonymous 1997Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156:S1–S25 - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K, on behalf of the ATS Mycobacterial Diseases Subcommittee 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367–416 - PubMed

Publication types

MeSH terms

LinkOut - more resources